Abnormal levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in human serum are the most sensitive indicator of hepatocellular damage. Because liver-related health problems are directly linked to elevated levels of ALT and AST, it is important to develop accurate and rapid methods to detect these enzymes for the early diagnosis of liver disease and prevention of long-term liver damage. Several analytical methods have been developed for the detection of ALT and AST. However, these methods are based on complex mechanisms and require bulky instruments and laboratories, making them unsuitable for point-of-care application or in-house testing. Lateral flow assay (LFA)-based biosensors, on the other hand, provide rapid, accurate, and reliable results, are easy to operate, and are affordable for low-income populations. However, due to the storage, stability, batch-to-batch variations, and error margins, antibody-based LFAs are considered unaffordable for field applications. In this hypothesis, we propose the selection of aptamers with high affinity and specificity for the liver biomarkers ALT and AST to build an efficient LFA device for point-of-care applications. Though the aptamer-based LFA would be semiquantitative for ALT and AST, it would be an inexpensive option for the early detection and diagnosis of liver disease. Aptamer-based LFA is anticipated to minimize the economic burden. It can also be used for routine liver function tests regardless of the economic situation in each country. By developing a low-cost testing platform, millions of patients suffering from liver disease can be saved.

In this study, photocatalysis was employed to degrade a wastewater pollutant (AB-29 dye) under visible light irradiation. For this purpose, nitrogen (N)- and neodymium (Nd)-doped TiO₂ nanoparticles were prepared using the simple hydrothermal method. X-ray diffraction (XRD) revealed an anatase phase structure of the Nd-N/TiO₂ photocatalyst, whereas properties including the surface morphology, chemical states/electronics structure and optical structure were determined using transmission electron microscopy (TEM), X-ray photoelectron spectroscopy (XPS) and UV–visible (UV–vis.) and photoluminescence (PL) spectroscopies. Photocatalytic testing of the prepared nanomaterials was performed to remove acid blue-29 (AB-29) dye under visible-light exposure. The prepared Nd-N/TiO₂ nanoparticles demonstrated a superior photocatalytic activity and the decolorization efficiency was about 92% after visible-light illumination for 1 h and 20 min, while N/TiO₂, Nd/TiO₂ and TiO₂ only showed a 67%, 43% and 31% decolorization efficiency, respectively. The enhanced photocatalytic activity of the Nd-N/TiO₂ photocatalyst was due to a decrease in the electron/hole’s recombination and the increased absorption of TiO₂ in the visible range. The reusability results showed that the average photocatalytic activity decrease for all the samples was only about 16% after five consecutive cycles, indicating a good stability of the prepared nanomaterials. Moreover, the radical scavenging activity of the prepared nanomaterials was evaluated using the DPPH method. The novel Nd-N/TiO₂ exhibited a higher antioxidant activity compared to all the other samples.

Lung cancer is the most commonly diagnosed of all cancers and one of the leading causes of cancer deaths among men and women worldwide, causing 1.5 million deaths every year. Despite developments in cancer treatment technologies and new pharmaceutical products, high mortality and morbidity remain major challenges for researchers. More than 75% of lung cancer patients are diagnosed in advanced stages, leading to poor prognosis. Lung cancer is a multistep process associated with genetic and epigenetic abnormalities. Rapid, accurate, precise, and reliable detection of lung cancer biomarkers in biological fluids is essential for risk assessment for a given individual and mortality reduction. Traditional diagnostic tools are not sensitive enough to detect and diagnose lung cancer in the early stages. Therefore, the development of novel bioanalytical methods for early-stage screening and diagnosis is extremely important. Recently, biosensors have gained tremendous attention as an alternative to conventional methods because of their robustness, high sensitivity, inexpensiveness, and easy handling and deployment in point-of-care testing. This review provides an overview of the conventional methods currently used for lung cancer screening, classification, diagnosis, and prognosis, providing updates on research and developments in biosensor technology for the detection of lung cancer biomarkers in biological samples. Finally, it comments on recent advances and potential future challenges in the field of biosensors in the context of lung cancer diagnosis and point-of-care applications.

Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are important liver enzymes in clinical settings. Their levels are known to be elevated in individuals with underlying liver diseases and those consuming hepatotoxic drugs. Serum ALT and AST levels are crucial for diagnosing and assessing liver diseases. Serum ALT is considered the most reliable and specific candidate as a disease biomarker for liver diseases. ALT and AST levels are routinely analyzed in high-risk individuals for the bioanalysis of both liver function and complications associated with drug-induced liver injury. Typically, ALT and AST require blood sampling, serum separation, and testing. Traditional methods require expensive or sophisticated equipment and trained specialists, which is often time-consuming. Therefore, developing countries have limited or no access to these methods. To address the above issues, we hypothesize that low-cost biosensing methods (paper-based assays) can be applied to the analysis of ALT and AST levels in biological fluids. The paper-based biodetection technique can semi-quantitatively measure ALT and AST from capillary finger sticks, and it will pave the way for the development of an inexpensive and rapid alternative method for the early detection and diagnosis of liver diseases. This method is expected to significantly reduce the economic burden and aid routine clinical analysis in both developed and underdeveloped countries. The development of low-cost testing platforms and their diagnostic utility will be extremely beneficial in helping millions of patients with liver disorders.

In this paper, we report on nanodisc-shaped MgCo₂O₄ wrapped with ZnS, achieved using the sol–gel-assisted hydrothermal method. This enhances the electrochemical performance, with the electrode delivering superior supercapacitive performance compared to MgCo₂O₄. Moreover, the nanodisc provides more active sites and allows smooth charge transfer during faradaic reactions. The nanodisc-shaped MgCo₂O₄ with ZnS delivers a capacitance of approximately 910 F/g at 1 A/g. The fabricated asymmetric capacitor is composed of MgCo₂O₄@ZnS and activated carbon (AC). The nanodisc-shaped MgCo₂O₄@ZnS provides more active sites and allows the smooth transport of electrons during long-term cycling. In addition, the electrode side reactions and electrolyte decomposition are significantly reduced due to the ZnS coating on the surface of the MgCo₂O₄, allowing this asymmetric capacitor to deliver an energy density of 43 Wh·kg⁻¹ at 1454 W·kg⁻¹. The performance of the asymmetric capacitor exhibits enhanced supercapacitive performance and opens a new way to investigate asymmetric supercapacitor devices.